While we did not perform molecular docking in this study, these established principles of protein–ligand interactions provide a foundation for understanding how the identified compounds may interfere with the biological activities of MMP9 and MGAM that contribute to bronchopulmonary dysplasia pathogenesis. This evidence concerns the gene MMP9 and bronchopulmonary dysplasia.